ALBI score and muscle loss in liver disease with confusion
Part of Digestive system clinical trials.
This study looks at how well two factors—a score called ALBI (a measure of liver function) and muscle wasting (sarcopenia)—can predict outcomes in people with cirrhosis who are hospitalized for confusion from liver disease. The goal is to see if these markers can help doctors better understand recovery and risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cirrhosis (scarring of the liver) and are currently hospitalized for hepatic encephalopathy (confusion from liver disease).
- You have not had a sudden, severe liver failure.
- You have not had a TIPS procedure or surgery to connect blood vessels in the liver.
- You have not had a liver or other organ transplant.
- You do not have end-stage kidney disease, liver cancer, or other tumors.
- You are not taking the blood thinner warfarin (Marivan) and do not have a blockage in the bile ducts outside the liver.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares new scoring tools to predict outcomes in people with liver cirrhosis who are hospitalized for sudden worsening (like fluid buildup, confusion, or bleeding). It aims to find which score works best to guide care.
This study looks at new blood markers to better predict recovery in patients hospitalized for complications of cirrhosis (like fluid buildup, confusion, or bleeding). You may qualify if you were recently hospitalized for these issues and are expected to go home soon.
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
This study looks at why some people with liver cirrhosis become confused after upper abdominal surgery. Researchers will use advanced lab tests to find clues, which could help prevent this confusion in the future.
This trial is testing new scoring systems to better predict how patients with acute-on-chronic liver failure will do. It may help doctors make more informed treatment decisions for people with this serious liver condition.
This study is creating a new test to measure thinking and memory problems in people with liver cirrhosis. It may help doctors find these problems earlier.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.